Active Ingredient(s):Bortezomib FDA Approved: * May 13, 2003 Pharm Company: *MILLENNIUM PHARMS Category:Cancer
Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection.
Common side effects include nausea, diarrhea, tiredness, low platelets, fever, numbness, low white blo...
* May have multiple approval dates, manufacturers, or labelers. 3 Discussions
Velcade 3.5 mg/1 Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution